MedTrace Logo

Frailty Evaluation in Elderly Population With Cancer

NCT03101631 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2017-05-30

No results posted yet for this study

Summary

The Comprehensive Geriatric Assessment (CGA) is, still today, barely established in the standard practice. Although the different scientific societies recommend a CGA in elderly population affected with cancer at first visit, the evidence regarding its transcendence is limited. On the other hand, the components of this evaluation and the translation of their findings in changes in the clinical practice are not stablished. This project intends to implement a CGA in a group of patients to compare this group with an historical cohort that reflects the standard practice, to evaluate the differences between both approaches. The study also evaluate the feasibility and utility of this CGA. All these questions aims to support the hypothesis that CGA impacts on the cancer treatment for elderly population affected with cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

Comprehensive Geriatric Assessment (CGA)

CGA includes a set of evaluations to determine therapeutic decision based on mortality risk, toxicity risk and frailty group. Evaluations includes: * Nutritional Assessment: Mini Nutritional Assessment (MNA) * Functional Assessment: Get up and Go, Activities of Daily Living (ADL), Instrumental Activities of Daily Living (IADL), Karnofsky Scale, Walking one Block, Number of Falls in last 6 months and Hearing Loss. * Cognitive Assessment: Mini-Mental State Examination (MMSE-30) * Psychological status: Geriatric Depression Scale (GDS) * Social Support: Medical Outcomes Study Social Support Survey (MOS-SSS) * Comorbidity and Severity of Comorbidities: Charlson Comorbidity Index and Adult Comorbidity Evaluation (ACE-27) * Age * Haemoglobin * CrCl * Presence of geriatric syndromes

Sponsors & Collaborators

  • Hospital General Universitario Elche

    collaborator OTHER

  • Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

    lead OTHER

Principal Investigators

  • Javier Gallego, PhD · HOSPITAL GENERAL UNIVERSITARIO DE ELCHE

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-02
Primary Completion
2014-07-30
Completion
2015-01-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03101631 on ClinicalTrials.gov